Yazar "Erdogan, Y." için listeleme
-
Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria
Alim, A.; Erdogan, Y.; Dayangac, M.; Yuzer, Y.; Tokat, Y.; Oezcelik, A. (SAGE Publications Ltd, 2021)Introduction: Liver transplantation offers the most reasonable expectation for curative treatment for hepatocellular carcinoma. Living-donor liver transplantation represents a treatment option, even in patients with extended ... -
The predictive value of risk indices for cardiac complications in living donor liver transplantation
Canbolat, I. P.; Erdogan, Y.; Adali, G.; Kaplan, O.; Dayangac, M.; Yuzer, Y.; Tokat, Y. (COMENIUS UNIV, 2018)BACKGROUND AND AIMS: The American College of Surgeons' National Surgical Quality Improvement Program (NSQIP) risk tool and Revised Cardiac Risk Index (RCRI) are recommended tools for cardiovascular assessment before ... -
Preoperative Liver Biopsy in Living Donor Liver Transplantation: Should Body Mass Index Solely Be a Liver Biopsy Indication?
Bozkurt, B.; Adali, G.; Dayangac, M.; Erdogan, Y.; Tokat, Y.; Yuzer, Y. (LIPPINCOTT WILLIAMS & WILKINS, 2017)… -
Splenic Artery Transposition for Arterial Reconstruction in Living Donor Liver Transplantation
Alim, A.; Dayangac, M.; Erdogan, Y.; Malamutmann, E.; Yuzer, Y.; Tokat, Y.; Oezcelik, A. (Elsevier USA, 2020)Purpose: in living donor liver transplantation, poor compatibility of the recipient hepatic artery remains a technical challenge. Here, we analyzed our 14 years of experience with extra-anatomic hepatic artery reconstruction. ... -
The Impact of Donor Macrovesicular Steatosis in Living Donor Liver Transplantation
Dayangac, M.; Adali, G.; Bozkurt, B.; Erdogan, Y.; Tokat, Y.; Yuzer, Y. (LIPPINCOTT WILLIAMS & WILKINS, 2017)…